Palmitic Acid
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB03796 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 20 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | non-syndromic esophageal malformation | KG + DL |
| 2 | esotropia | KG + DL |
| 3 | esophageal disease | KG + DL |
| 4 | HER2 positive breast carcinoma | KG + DL |
| 5 | atypical coarctation of aorta | KG + DL |
| 6 | dry eye syndrome | KG + DL |
| 7 | progesterone-receptor positive breast cancer | KG + DL |
| 8 | normal breast-like subtype of breast carcinoma | KG + DL |
| 9 | breast tumor luminal A or B | KG + DL |
| 10 | progesterone-receptor negative breast cancer | KG + DL |
| 11 | aortic malformation | KG + DL |
| 12 | bone Paget disease | KG + DL |
| 13 | migraine disorder | KG + DL |
| 14 | migraine with brainstem aura | KG + DL |
| 15 | multiple endocrine neoplasia | KG + DL |
| 16 | human herpesvirus 8-related tumor | KG + DL |
| 17 | ectomesenchymoma | KG + DL |
| 18 | malignant cutaneous granular cell skin tumor | KG + DL |
| 19 | middle ear neuroendocrine tumor | KG + DL |
| 20 | Sjogren syndrome | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.